http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6162803-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 |
| filingDate | 1999-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f677273f84e4f74c8b79d51fd6cf423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02cfff89f8b36d8473b40c51ea0ba559 |
| publicationDate | 2000-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6162803-A |
| titleOfInvention | Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression |
| abstract | Compounds effective in treating disorders of the serotonin-affected neurological symptoms are provided, such compounds having the following formula: wherein: R1 and R5 are each, independently, hydrogen, halogen, lower alkoxy, lower alkyl, cyano, or trifluoromethyl; R2 and R4 are each, independently, hydrogen, lower alkyl, phenyl, or substituted phenyl; R3 is hydrogen or lower alkyl; and X and Y are each, independently, O, NR6, or CH2, wherein R6 is hydrogen, lower alkyl, phenyl, or substituted phenyl; or pharmaceutically acceptable salts thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004171667-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6911445-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004180883-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03006455-A1 |
| priorityDate | 1998-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 151.